ENID, Okla., Sept. 17, 2018 /PRNewswire-PRWeb/ -- Enid Urology Associates today announced that their 350th patient has
"The UroLift System preserves sexual function which is important to men and their partners," says Drs. Kruska and Colvert "Best of all, they experience rapid symptom relief and return to normal routines quickly," they add.
Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.
Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring additional treatment for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.
About the UroLift System
NeoTract's FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the treatment. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.urolift.com/.
About ENID Urology Associates, Inc. Established in 1970, Enid Urology Associates, Inc., specializes in urology. We welcome you as a patient and appreciate the opportunity to serve your health care needs.
Doctor-patient relationships are best when based upon mutual understanding. We make a special effort to explain everything to you regarding your condition, medicines, treatment, surgery, etc. If you ever have questions, or if something is not clear to you, please do not hesitate to ask. We have chosen our office personnel, office procedures, and medical equipment with much thought and care to provide quality medical services in an efficient, friendly atmosphere. If you have any suggestions or complaints regarding our services, please tell us, so that we may better serve you and your family.
We feel it is important for our patients and their families to understand as much as possible about their urology problems. We have videotapes available on some topics for viewing in the office, and free pamphlets on a variety of urologic problems to take home. For more information, please visit http://enidurologyassociates.com/.
To schedule a consultation with Enid Urology Associates, please call 580-233-3230.
1 Roehrborn et al. EAU Abstract_ Eur Urol Suppl 2017; 16(3):e192. 2 Sonksen et al J Urology 2016 MAC00359-01 RevB
SOURCE Enid Urology Associates
Subscribe to our Free Newsletters!